6505--Lenalidomide (Revlimid) Dose - Brand name or Equal

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

252-NETWORK CONTRACT OFFICE 12 (36C252)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25226Q0097

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Chicago, Illinois, UNITED STATES

SourceSAM
Documents1
This Sources Sought Notice, issued under procurement identifier 36C25226Q0097, is released by the Department of Veterans Affairs (VA), specifically the Jesse Brown VA Medical Center located at 820 South Damen Avenue, Chicago, IL 60612-4223. The notice is for informational and planning purposes only and does not constitute a solicitation or a commitment by the Government. The primary objective is to conduct market research to identify capable sources, including both small and other-than-small businesses, with a particular interest in VIP-Verified Veteran-Owned Small Businesses (VOSB) and Service-Disabled Veteran-Owned Small Businesses (SDVOSB), that can provide Lenalidomide (Revlimid) or an equivalent pharmaceutical product. **Purpose and Scope** The VA Pharmacy Service Department requires the procurement and delivery of Lenalidomide (Revlimid) capsules, a critical medication used in the treatment of multiple myeloma, certain myelodysplastic syndromes (specifically deletion 5q MDS), mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma. Due to the significant risks associated with embryo-fetal exposure, Lenalidomide is distributed exclusively through the Lenalidomide Risk Evaluation and Mitigation Strategy (REMS) program. Only pharmacies certified under the Lenalidomide REMS program are authorized to dispense this medication to enrolled and compliant patients. The intended outcome of this procurement is to ensure that eligible veterans receive timely access to Lenalidomide or its equivalent, in strict adherence to REMS requirements, thereby supporting optimal patient care and safety. **Key Requirements and Deliverables** - **Product Specification:** The requirement is for Lenalidomide (Revlimid) capsules in various strengths (2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg), with estimated quantities specified for certain dosages (e.g., 1,596 units of 10mg and 210 units of 25mg). - **Certification:** Vendors must be certified under the Lenalidomide REMS program, as the pharmacy network is closed to new applicants. Only certified pharmacies can dispense the medication. - **Prescription Fulfillment:** The contractor will be responsible for receiving prescriptions from the VA, verifying REMS authorization, coordinating with patients for counseling, and ensuring delivery either to the VA pharmacy or directly to the patient, as indicated. - **Delivery and Handling:** The contractor must ensure proper handling, storage, and transportation of the medication, maintaining integrity and compliance with all applicable regulations. Shipping fees to the FOB destination (Jesse Brown VA Medical Center) must not exceed $250. - **Patient and Provider Support:** The contractor is expected to provide clinical support, financial assistance coordination, adherence support, refill reminders, and exceptional patient and caregiver support. - **Reporting and Communication:** The contractor must report missing delivery confirmations, address long hold times or incorrect information, and coordinate with the VA for STAT prescriptions or unresolved patient contact issues. - **Payment and Invoicing:** Payments will be processed upon delivery and acceptance, using the Tungsten Network for e-invoicing. **Contracting Entity and Classification** - **Contracting Office:** 252-Network Contract Office 12 (36C252), a federal entity. - **NAICS Code:** 325412 (Pharmaceutical Preparation Manufacturing), with a size standard of 1,300 employees. - **PSC Code:** 6505 (Drugs and Biologicals). - **Place of Performance:** Chicago, Illinois, United States. **Procurement Type and Special Considerations** This notice is a Sources Sought/Request for Information (RFI) and not a solicitation. It is strictly for market research to assess the availability and capability of potential vendors. The procurement is subject to the limitations and requirements of the Lenalidomide REMS program, which restricts dispensing to a closed network of certified pharmacies. There are no set-aside requirements specified at this stage, but responses from all business sizes, including SDVOSB and VOSB, are encouraged. **Response Instructions and Contact Information** Interested parties must be registered in the System for Award Management (SAM) and have current Online Representations and Certifications. Responses should include a capabilities statement addressing the ability to meet the Statement of Work (SOW) requirements, business size and status, distributor or manufacturer status, compliance with subcontracting limitations, and other requested information. General pricing is encouraged for market research purposes only. - **Primary Contact:** Arneil Genus - **Email:** [email protected] (responses by email only) - **Response Deadline:** November 20, 2025, 3:00 PM CST **Constant Elements Over Contract Lifecycle** Throughout the contract, the requirement for REMS certification, strict adherence to prescription and delivery protocols, compliance with all regulatory and safety standards, and the provision of comprehensive patient and provider support will remain unchanged. The place of performance, payment processing procedures, and the need for coordination with the VA’s designated points of contact are also consistent elements. This opportunity is best suited for certified specialty pharmacies with established REMS program participation, robust patient support infrastructure, and proven experience in handling and delivering high-risk pharmaceutical products in compliance with federal regulations. For further details and to access the official notice, visit: [SAM.gov Opportunity ID de4403590121447f98bff17fc34bac39](https://sam.gov/opp/de4403590121447f98bff17fc34bac39/view).